Beta Bionics, Inc. BBNX
15.14 USD -0.76 (-4.78%)
Nov 3, 2026, 3:28 PM EST
15.00 Day range 16.06
8.86 52-week range 31.99
- YTD
- -50.31%
- 1 year
- -45.34%
Analyst view
Price target (mean) 24.24 +60.1% upside
Now 15.14
- Target (low)
- 16.00
- Target (mean)
- 24.24
- Target (high)
- 30.40
Ratings (0m) 15 11 buy · 4 hold · 0 sell
- Strong buy2
- Buy9
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 13
- 2 months ago 12
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.51333 | -0.55 – -0.46 | -0.33 | -55.5% | 34.59M | +26.9% | 3 |
| Next quarter | -0.44 | -0.52 – -0.40 | -0.19 | -131.6% | 30.15M | -6.1% | 3 |
| Current year | -1.88 | -2.06 – -1.61 | -1.38 | -36.4% | 124.36M | +24.0% | 3 |
| Next year | -2.16 | -2.49 – -1.83 | -1.88 | -14.9% | 182.64M | +46.9% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Jefferies | Initiated | — | Buy |
| Sep 24, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 23, 2026 | Wells Fargo | Initiated | — | Overweight |
| Sep 15, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Sep 15, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Sep 15, 2026 | Baird | Maintained | Neutral | Neutral |
| Sep 14, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 21, 2026 | William Blair | Initiated | — | Market Perform |
| Jul 15, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 13, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 27, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| May 18, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Apr 22, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Apr 22, 2026 | Stifel | Maintained | Buy | Buy |
| Apr 15, 2026 | Truist Securities | Maintained | Buy | Buy |
| Apr 9, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Feb 18, 2026 | Stifel | Maintained | Buy | Buy |
| Feb 18, 2026 | Baird | Maintained | Neutral | Neutral |
| Feb 4, 2026 | Stifel | Maintained | Buy | Buy |
| Feb 2, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jan 27, 2026 | TD Cowen | Initiated | — | Hold |
| Jan 9, 2026 | Lake Street | Maintained | Buy | Buy |
| Jan 5, 2026 | B of A Securities | Maintained | Buy | Buy |
| Dec 18, 2025 | Truist Securities | Maintained | Buy | Buy |
| Oct 29, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Oct 29, 2025 | Stifel | Reiterated | Buy | Buy |
| Oct 29, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Oct 29, 2025 | Piper Sandler | Reiterated | Overweight | Overweight |
| Oct 1, 2025 | Goldman Sachs | Upgrade | Neutral | Buy |
| Sep 22, 2025 | Truist Securities | Maintained | Buy | Buy |